Poster sessions at WCLC 2026 detail how surgery, nursing, and pathology can contribute to the multidisciplinary care of patients with lung cancer.
|Videos|June 11, 2019
Dr. Arbour on the Latest Data for Checkpoint Inhibitors for Lung Cancer in 2019
Author(s)Kathryn Cecilia Arbour, MD
Cancer Network spoke with Kathryn Cecilia Arbour, MD, of Memorial Sloan-Kettering Cancer Center, about the most recent research on checkpoint inhibitors in oncology.
Advertisement
Cancer Network spoke with Kathryn Cecilia Arbour, MD, medical oncologist at Memorial Sloan-Kettering Cancer Center, about the most recent research on checkpoint inhibitors in the treatment of cancer. Dr. Arbour presented this data during an educational session at ASCO 2019.
Advertisement
Related to this article
Medical oncologists, clinical pharmacists, and oncologic nurse practitioners share the presentation topics to look out for at WCLC 2026.
Advertisement
Advertisement
Trending on CancerNetwork
1
Lutetium Lu 177 Dotatate Biosimilar Earns Final FDA Approval in GEP-NETs
2
PANXEON Liquid Biopsy Demonstrates Potential for Detecting Early Pancreatic Cancer
3
Rusfertide Earns Category 1 NCCN Recommendation in Polycythemia Vera
4
AdenoVerse Platform Receives FDA Designation for HPV-Associated Cancers
5